Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Renal Market Research

Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 197 Pages 360iResearch January, 2024 IRE18418301
Best Price Guarantee
Price from $4,749
Length 197 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18418301

Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Global Forecast 2024-2030


The Anemia Drugs Market size was estimated at USD 19.55 billion in 2023 and expected to reach USD 21.24 billion in 2024, at a CAGR 10.76% to reach USD 39.99 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anemia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anemia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anemia Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc. by Allergan PLC, ADZO Lifesciences Pvt Ltd., Akebia Therapeutics, Inc., Alembic Pharmaceuticals Limited, Alkem Laboratories Ltd., Aqunova Pharma Private Limited, Astraea Life Sciences Pvt Ltd, Bluebird Bio, Inc., Cadila Pharmaceuticals Ltd., Corona Remedies Pvt Ltd., Covis Pharma GmbH, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals Ltd., GSK PLC, Gujarat Terce Laboratories Ltd., Lupin Ltd., Pfizer Inc., Pharmacosmos A/S, Pieris Pharmaceuticals, Inc., Sanofi S.A., Solitaire Pharmacia Pvt. Ltd., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, and Triton Healthcare Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Anemia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug

Alglucerase Injection
  • Carbonyl Iron
  • Cyanocobalamin
  • Darbepoetin Alfa
  • Eculizumab
  • Epoetin Beta-methoxy Polyethylene Glycol
  • Ferrous FumarateIron
  • Iron Dextran
  • Iron Supplements
  • Type

    Aplastic Anemia
  • Chronic Kidney Disease Anemia
  • Hemolytic Anemia
  • Iron Deficiency Anemia
  • Pernicious Anemia
  • Sickle Cell Anemia
  • Vitamin Deficiency Anemia
  • Route of Administration

    Injectable
  • Oral
  • End-Users

    Hospital
  • Self-Administered
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Anemia Drugs Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anemia Drugs Market?
    3. What are the technology trends and regulatory frameworks in the Anemia Drugs Market?
    4. What is the market share of the leading vendors in the Anemia Drugs Market?
    5. Which modes and strategic moves are suitable for entering the Anemia Drugs Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Anemia Drugs Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalence of chronic diseases and anemia
    5.1.1.2. Changing lifestyles and over-consumption of packaged and processed foods
    5.1.1.3. Shifting demographics and growing number of women in reproductive stages
    5.1.2. Restraints
    5.1.2.1. Side effects associated with overconsumption of anemia drugs
    5.1.3. Opportunities
    5.1.3.1. Government approvals for the development of new and innovative anemia drugs
    5.1.3.2. Research and development activities for the production of anemia drugs
    5.1.4. Challenges
    5.1.4.1. Recall of anemia drugs over safety concerns
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Anemia Drugs Market, by Drug
    6.1. Introduction
    6.2. Alglucerase Injection
    6.3. Carbonyl Iron
    6.4. Cyanocobalamin
    6.5. Darbepoetin Alfa
    6.6. Eculizumab
    6.7. Epoetin Beta-methoxy Polyethylene Glycol
    6.8. Ferrous FumarateIron
    6.9. Iron Dextran
    6.10. Iron Supplements
    7. Anemia Drugs Market, by Type
    7.1. Introduction
    7.2. Aplastic Anemia
    7.3. Chronic Kidney Disease Anemia
    7.4. Hemolytic Anemia
    7.5. Iron Deficiency Anemia
    7.6. Pernicious Anemia
    7.7. Sickle Cell Anemia
    7.8. Vitamin Deficiency Anemia
    8. Anemia Drugs Market, by Route of Administration
    8.1. Introduction
    8.2. Injectable
    8.3. Oral
    9. Anemia Drugs Market, by End-Users
    9.1. Introduction
    9.2. Hospital
    9.3. Self-Administered
    10. Americas Anemia Drugs Market
    10.1. Introduction
    10.2. Argentina
    10.3. Brazil
    10.4. Canada
    10.5. Mexico
    10.6. United States
    11. Asia-Pacific Anemia Drugs Market
    11.1. Introduction
    11.2. Australia
    11.3. China
    11.4. India
    11.5. Indonesia
    11.6. Japan
    11.7. Malaysia
    11.8. Philippines
    11.9. Singapore
    11.10. South Korea
    11.11. Taiwan
    11.12. Thailand
    11.13. Vietnam
    12. Europe, Middle East & Africa Anemia Drugs Market
    12.1. Introduction
    12.2. Denmark
    12.3. Egypt
    12.4. Finland
    12.5. France
    12.6. Germany
    12.7. Israel
    12.8. Italy
    12.9. Netherlands
    12.10. Nigeria
    12.11. Norway
    12.12. Poland
    12.13. Qatar
    12.14. Russia
    12.15. Saudi Arabia
    12.16. South Africa
    12.17. Spain
    12.18. Sweden
    12.19. Switzerland
    12.20. Turkey
    12.21. United Arab Emirates
    12.22. United Kingdom
    13. Competitive Landscape
    13.1. FPNV Positioning Matrix
    13.2. Market Share Analysis, By Key Player
    13.3. Competitive Scenario Analysis, By Key Player
    14. Competitive Portfolio
    14.1. Key Company Profiles
    14.1.1. AbbVie Inc. by Allergan PLC
    14.1.2. ADZO Lifesciences Pvt Ltd.
    14.1.3. Akebia Therapeutics, Inc.
    14.1.4. Alembic Pharmaceuticals Limited
    14.1.5. Alkem Laboratories Ltd.
    14.1.6. Aqunova Pharma Private Limited
    14.1.7. Astraea Life Sciences Pvt Ltd
    14.1.8. Bluebird Bio, Inc.
    14.1.9. Cadila Pharmaceuticals Ltd.
    14.1.10. Corona Remedies Pvt Ltd.
    14.1.11. Covis Pharma GmbH
    14.1.12. Dr. Reddy's Laboratories
    14.1.13. Emcure Pharmaceuticals
    14.1.14. Glenmark Pharmaceuticals Ltd.
    14.1.15. GSK PLC
    14.1.16. Gujarat Terce Laboratories Ltd.
    14.1.17. Lupin Ltd.
    14.1.18. Pfizer Inc.
    14.1.19. Pharmacosmos A/S
    14.1.20. Pieris Pharmaceuticals, Inc.
    14.1.21. Sanofi S.A.
    14.1.22. Solitaire Pharmacia Pvt. Ltd.
    14.1.23. Sun Pharmaceutical Industries Limited
    14.1.24. Takeda Pharmaceutical Company Limited
    14.1.25. Triton Healthcare Pvt Ltd.
    14.2. Key Product Portfolio
    15. Appendix
    15.1. Discussion Guide
    15.2. License & Pricing
    FIGURE 1. ANEMIA DRUGS MARKET RESEARCH PROCESS
    FIGURE 2. ANEMIA DRUGS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANEMIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANEMIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANEMIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANEMIA DRUGS MARKET DYNAMICS
    FIGURE 7. ANEMIA DRUGS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
    FIGURE 8. ANEMIA DRUGS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANEMIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 10. ANEMIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
    FIGURE 12. ANEMIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
    FIGURE 14. ANEMIA DRUGS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. AMERICAS ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 18. UNITED STATES ANEMIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. ASIA-PACIFIC ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANEMIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. ANEMIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 24. ANEMIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings